Challenge

Lonza’s Clients required Biopharmaceutical manufacturing capacity in order to meet pilot and launch quantities of drugs for chronic ailments. To de-risk lower than forecast sales, greater attrition between phase 3, and launch scale, and process changes resulting  from improved manufacturing yield Lonza’s Clients were urgently seeking contract manufacturers who had flexibility and capacity.

Solution

Bob lead a strategic team to create a portfolio of projects which would meet this need. The projects were:

  • Supply chain management and cost reduction
  • Operational improvement of cell culture, fermentation and purification
  • Technology change to allow flexible scale and quick change manufacturing
  • Improved performance from which to build excellence in FDA and EMA compliance inspections.

Result

Implementing this strategic plan and delivering the projects achieved:

  • Fast adaptable growth in contract manufacturing capacity availability
  • Customer relationships built on capability and reduced time to market
  • Profitability at lower capacities
  • Increased manufacturing capacity and development capability
  • A manufacturing innovation pipeline